Charles Wilson is the founder of UNUM Therapeutics. UNUM Therapeutics has raised $77M in total funding. Latest round: Series B. Based in Cambridge, MA, USA.
Charles Wilson, Ph.D., is the President and Chief Executive Officer of Unum Therapeutics. Unum Therapeutics is a biotechnology company focused on developing a universal, antibody-directed cellular immunotherapy. The company raised $65 million in a Series B financing round in June 2015 to advance its Antibody-Coupled T-cell Receptor (ACTR) technology platform and expand its pipeline of ACTR therapies for hematological and solid tumor indications.
Full founder directory · Investor directory · Company funding database · Fundraising library